Syndrome  >>  Aptivus (tipranavir)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Aptivus (tipranavir) / Boehringer Ingelheim
NCT00192660: HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Completed
4
80
RoW
Lamivudine, Stavudine, Didanosine, Zidovudine, Tenofovir, Abacavir, Efavirenz (EFV), Nevirapine, Indinavir, Saquinavir, Amprenavir, Ritonavir, Nelfinavir, Tipranavir, enfuvirtide (T20)
Kirby Institute, St Vincent's Hospital, Sydney, National Heart, Lung, and Blood Institute (NHLBI)
HIV-Associated Lipodystrophy Syndrome, Cardiovascular Disease
10/06
12/07

Download Options